Quantamental Technologies’s Quest Diagnostics DGX Stock Holding History

Quantamental Technologies’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$422K	Buy	3,466 +841	+32%	+$112K	0.4%	98
2023 Q2	$369K	Buy	+2,625	New	+$362K	0.15%	229
2021 Q4	–	Sell	-4,447	Closed	-$646K	–	414
2021 Q3	$646K	Buy	+4,447	New	+$651K	0.43%	81
2019 Q4	–	Sell	-5,941	Closed	-$636K	–	650
2019 Q3	$636K	Buy	5,941 +1,741	+41%	+$179K	0.21%	107
2019 Q2	$428K	Buy	+4,200	New	+$404K	0.16%	186

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quantamental Technologies's DGX Position: Q3 2023 in Review

Quantamental Technologies increased its Quest Diagnostics (DGX) stake by 32% in Q3 2023, buying an estimated $112K and bringing the position to 3,466 shares worth $422K. The position accounts for 0.4% of the portfolio, ranked #98.

Quantamental Technologies first reported a position in DGX in Q2 2019 and has held it in 5 quarters since. The position peaked at $646K in Q3 2021. 795 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

Quantamental Technologies held 3,466 shares of Quest Diagnostics worth $422K as of Q3 2023.
Quantamental Technologies bought 841 Quest Diagnostics shares in Q3 2023, an estimated $112K.
Quest Diagnostics made up 0.4% of Quantamental Technologies's portfolio in Q3 2023, its #98 holding.
Quantamental Technologies first reported a position in Quest Diagnostics in Q2 2019 and has held it in 5 quarters since.
Quantamental Technologies's Quest Diagnostics position peaked at $646K in Q3 2021.
795 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.